Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Common Share

v3.10.0.1
Earnings Per Common Share
9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
Earnings Per Common Share
Earnings Per Common Share
The calculation of earnings per common share (EPS) and diluted EPS for the three and nine months ended September 30, 2018 and 2017 is presented below. For more information on the calculation of EPS, see Note 1 – Summary of Significant Accounting Principles to the Consolidated Financial Statements of the Corporation’s 2017 Annual Report on Form 10-K.
 
 
 
 
 
 
 
 
 
Three Months Ended September 30
 
Nine Months Ended September 30
(In millions, except per share information)
2018
 
2017
 
2018
 
2017
Earnings per common share
 

 
 

 
 
 
 
Net income
$
7,167

 
$
5,424

 
$
20,869

 
$
15,867

Preferred stock dividends
(466
)
 
(465
)
 
(1,212
)
 
(1,328
)
Net income applicable to common shareholders
$
6,701

 
$
4,959

 
$
19,657

 
$
14,539

Average common shares issued and outstanding
10,031.6

 
10,197.9

 
10,177.5

 
10,103.4

Earnings per common share
$
0.67

 
$
0.49

 
$
1.93

 
$
1.44

 
 
 
 
 
 
 
 
Diluted earnings per common share
 

 
 

 
 
 
 
Net income applicable to common shareholders
$
6,701

 
$
4,959

 
$
19,657

 
$
14,539

Add preferred stock dividends due to assumed conversions (1)

 
37

 

 
187

Net income allocated to common shareholders
$
6,701

 
$
4,996

 
$
19,657

 
$
14,726

Average common shares issued and outstanding
10,031.6

 
10,197.9

 
10,177.5

 
10,103.4

Dilutive potential common shares (2)
139.2

 
548.8

 
140.4

 
728.7

Total diluted average common shares issued and outstanding
10,170.8

 
10,746.7

 
10,317.9

 
10,832.1

Diluted earnings per common share
$
0.66

 
$
0.46

 
$
1.91

 
$
1.36

(1) 
Represents the Series T dividends under the “if-converted” method prior to conversion.
(2) 
Includes incremental dilutive shares from restricted stock units, restricted stock and warrants.
The Corporation previously issued warrants to purchase 700 million shares of the Corporation’s common stock to the holders of the Series T 6% Non-cumulative preferred stock (Series T). In the third quarter of 2017, the Series T holders exercised the warrants and acquired the 700 million shares of the Corporation’s common stock. For the three and nine months ended September 30, 2017, the average dilutive impact of the 700 million potential common shares was included in the diluted share count under the “if-converted” method.
For both the three and nine months ended September 30, 2018 and 2017, 62 million average dilutive potential common shares associated with the Series L preferred stock were not included in the diluted share count because the result would have been antidilutive under the “if-converted” method. For the three and nine months ended September 30, 2018, average options to purchase two million and five million shares of common stock were outstanding but not included in the computation of EPS because the result would have been antidilutive under the treasury stock method compared to 18 million and 22 million for the same periods in 2017. For the three and nine months ended September 30, 2018, average warrants to purchase 135 million and 139 million shares of common stock were included in the diluted EPS calculation under the treasury stock method compared to 150 million shares of common stock for both periods in 2017. For both the three and nine months ended September 30, 2018 and 2017, average warrants to purchase 122 million shares of common stock were outstanding but not included in the computation of EPS because the result would have been antidilutive under the treasury stock method.